AstraZeneca plc vs Wells Fargo & Co — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Wells Fargo & Co trades at $87.48 (market cap $264.66B). The key difference: AstraZeneca plc and Wells Fargo & Co are close in size by market cap, and Wells Fargo & Co pays the higher dividend (2.29%). Which is the better fit depends on your goals.
| AZN | WFC | |
|---|---|---|
Market Cap | $248.14B | $264.66B |
Sector | Health | Financials |
52-Week High | $209.48 | $96.40 |
52-Week Low | $147.06 | $73.42 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | 2.29% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →